BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12960829)

  • 41. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
    Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
    CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
    Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical Chemoradiation.
    Simonds HM; Neugut AI; Jacobson JS
    Int J Gynecol Cancer; 2015 Jun; 25(5):884-90. PubMed ID: 25853380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.
    Franceschi S; Rajkumar T; Vaccarella S; Gajalakshmi V; Sharmila A; Snijders PJ; Muñoz N; Meijer CJ; Herrero R
    Int J Cancer; 2003 Oct; 107(1):127-33. PubMed ID: 12925967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of HIV testing among women diagnosed with invasive cervical cancer in the New Jersey Medicaid Program.
    McGee-Avila JK; Doose M; Nova J; Kumar R; Stroup AM; Tsui J
    Cancer Causes Control; 2020 Oct; 31(10):931-941. PubMed ID: 32803402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accelerated Epigenetic Age Among Women with Invasive Cervical Cancer and HIV-Infection in Nigeria.
    Musa J; Kim K; Zheng Y; Qu Y; Joyce BT; Wang J; Nannini DR; Gursel DB; Silas O; Abdulkareem FB; Imade G; Akanmu AS; Wei JJ; Kocherginsky M; Kim KA; Wehbe F; Achenbach CJ; Anorlu R; Simon MA; Sagay A; Ogunsola FT; Murphy RL; Hou L
    Front Public Health; 2022; 10():834800. PubMed ID: 35570901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of women with AIDS and invasive cervical cancer.
    Klevens RM; Fleming PL; Mays MA; Frey R
    Obstet Gynecol; 1996 Aug; 88(2):269-73. PubMed ID: 8692514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of HIV serological status on outcome in patients with cancer of cervix treated with radiotherapy.
    Kigula-Mugambe JB; Kavuma A
    East Afr Med J; 2006 Aug; 83(8):416-23. PubMed ID: 17153654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of cervical neoplasia.
    Robinson W
    Cancer Treat Res; 2001; 104():287-302. PubMed ID: 11227083
    [No Abstract]   [Full Text] [Related]  

  • 50. Invasive cervical cancer risk among HIV-infected women is a function of CD4 count and screening.
    Abraham AG; Strickler HD; D'Souza G
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e163. PubMed ID: 24135779
    [No Abstract]   [Full Text] [Related]  

  • 51. INVASIVE CERVICAL CANCER IN IBADAN: SOCIO-SEXUAL CHARACTERISTICS, CLINICAL STAGE AT PRESENTATION, HISTOPATHOLOGY DISTRIBUTIONS AND HIV STATUS.
    Awolude OA; Oyerinde SO
    Afr J Infect Dis; 2019; 13(1):32-38. PubMed ID: 30596194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology and survival outcomes of HIV-associated cervical cancer in Nigeria.
    Musa J; Kocherginsky M; Magaji FA; Maryam AJ; Asufi J; Nenrot D; Burdett K; Katam N; Christian EN; Palanisamy N; Odukoya O; Silas OA; Abdulkareem F; Akpa P; Badmos K; Imade GE; Akanmu AS; Gursel DB; Zheng Y; Joyce BT; Achenbach CJ; Sagay AS; Anorlu R; Wei JJ; Ogunsola F; Murphy RL; Hou L; Simon MA
    Infect Agent Cancer; 2023 Nov; 18(1):68. PubMed ID: 37915091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology and Survival outcomes of HIV-associated cervical cancer in Nigeria.
    Musa J; Kocherginsky M; Magaji FA; Maryam AJ; Asufi J; Nenrot D; Burdett K; Katam N; Christian EN; Palanisamy N; Odukoya O; Silas OA; Abdulkareem F; Akpa P; Badmos K; Imade GE; Akanmu AS; Gursel DB; Zheng Y; Joyce BT; Achenbach CJ; Sagay AS; Anorlu R; Wei JJ; Ogunsola F; Murphy RL; Hou L; Simon MA
    medRxiv; 2023 Aug; ():. PubMed ID: 37609183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is the level of proof of the North American multicohort collaboration prospective study sufficient to conclude that incidence of invasive cervical cancer is higher in HIV-infected women?
    Nazac A; Fridmann S; Boufassa F
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e163-4. PubMed ID: 24135780
    [No Abstract]   [Full Text] [Related]  

  • 55. A Dire Presentation of Carcinoma Cervix in a Human Immunodeficiency Virus-Positive Case: A Salient Display.
    Pamnani S; Bakshi SS; Chakole S
    Cureus; 2023 Sep; 15(9):e45605. PubMed ID: 37868493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Pattern of Cervical Cancer according to HIV Status in Yaoundé, Cameroon.
    Tebeu PM; Ngou-Mve-Ngou JP; Zingué LL; Antaon JSS; Okobalemba Atenguena E; Dohbit JS
    Obstet Gynecol Int; 2021; 2021():1999189. PubMed ID: 35190744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa.
    Ibrahim Khalil A; Mpunga T; Wei F; Baussano I; de Martel C; Bray F; Stelzle D; Dryden-Peterson S; Jaquet A; Horner MJ; Awolude OA; Trejo MJ; Mudini W; Soliman AS; Sengayi-Muchengeti M; Coghill AE; van Aardt MC; De Vuyst H; Hawes SE; Broutet N; Dalal S; Clifford GM
    Int J Cancer; 2022 Mar; 150(5):761-772. PubMed ID: 34626498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human immune deficiency virus among cervical cancer patients at Tikur Anbessa Specialized Hospital, Ethiopia: a cross sectional study.
    Wassie M; Fentie B; Asefa T
    BMC Womens Health; 2021 Aug; 21(1):294. PubMed ID: 34372828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cervical cancer diagnosis and treatment delays in the developing world: Evidence from a hospital-based study in Zambia.
    Mumba JM; Kasonka L; Owiti OB; Andrew J; Lubeya MK; Lukama L; Kasempa C; Msadabwe SC; Kalinda C
    Gynecol Oncol Rep; 2021 Aug; 37():100784. PubMed ID: 34095422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya.
    Mungo C; Osongo CO; Ambaka J; Randa MA; Omoto J; Cohen CR; Huchko M
    JCO Glob Oncol; 2020 Jul; 6():1024-1033. PubMed ID: 32634066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.